Price Alert

Amgen Inc. (AMGN)

NASDAQ: AMGN · Real-Time Price · USD

283.64

3.54 (1.26%)

At close: Sep 05, 2025, 3:59 PM

283.19

-0.16%

After-hours: Sep 05, 2025, 07:16 PM EDT

Amgen Statistics

Share Statistics

Amgen has 538.36M shares outstanding. The number of shares has increased by 0.07% in one year.

Shares Outstanding	538.36M
Shares Change (YoY)	0.07%
Shares Change (QoQ)	0.09%
Owned by Institutions (%)	78.43%
Shares Floating	537.3M
Failed to Deliver (FTD) Shares	1,585
FTD / Avg. Volume	0.07%

Short Selling Information

The latest short interest is 10.87M, so 2.02% of the outstanding shares have been sold short.

Short Interest	10.87M
Short % of Shares Out	2.02%
Short % of Float	2.03%
Short Ratio (days to cover)	4.58

Valuation Ratios

The PE ratio is 34.48 and the forward PE ratio is 12.93. Amgen's PEG ratio is -0.87.

PE Ratio	34.48
Forward PE	12.93
PS Ratio	4.22
Forward PS	4.2
PB Ratio	23.99
P/FCF Ratio	13.57
PEG Ratio	-0.87

Financial Ratio History

Enterprise Valuation

Amgen has an Enterprise Value (EV) of 189.13B.

EV / Sales	5.66
EV / EBITDA	14.16
EV / EBIT	16.46
EV / FCF	18.2

Financial Position

The company has a current ratio of 1.26, with a Debt / Equity ratio of 10.23.

Current Ratio	1.26
Quick Ratio	0.95
Debt / Equity	10.23
Debt / EBITDA	4.5
Debt / FCF	5.78
Interest Coverage	2.3

Financial Efficiency

Return on Equity is 69.59% and Return on Invested Capital is 8.91%.

Return on Equity	69.59%
Return on Assets	4.45%
Return on Invested Capital	8.91%
Revenue Per Employee	$1.19M
Profits Per Employee	$146.07K
Employee Count	28,000
Asset Turnover	0.36
Inventory Turnover	1.84

Taxes

Income Tax	519M
Effective Tax Rate	11.26%

Stock Price Statistics

The stock price has increased by -11.52% in the last 52 weeks. The beta is 0.48, so Amgen's price volatility has been higher than the market average.

Beta	0.48
52-Week Price Change	-11.52%
50-Day Moving Average	293.25
200-Day Moving Average	288.02
Relative Strength Index (RSI)	41.89
Average Volume (20 Days)	2,239,616

Income Statement

In the last 12 months, Amgen had revenue of 33.42B and earned 4.09B in profits. Earnings per share was 7.56.

Revenue	33.42B
Gross Profit	20.57B
Operating Income	7.26B
Net Income	4.09B
EBITDA	13.36B
EBIT	7.76B
Earnings Per Share (EPS)	7.56

Full Income Statement

Balance Sheet

The company has 11.97B in cash and 60.1B in debt, giving a net cash position of -48.13B.

Cash & Cash Equivalents	11.97B
Total Debt	60.1B
Net Cash	-48.13B
Retained Earnings	-27.59B
Total Assets	87.9B
Working Capital	6.26B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 11.49B and capital expenditures -1.1B, giving a free cash flow of 10.39B.

Operating Cash Flow	11.49B
Capital Expenditures	-1.1B
Free Cash Flow	10.39B
FCF Per Share	19.21

Full Cash Flow Statement

Margins

Gross margin is 61.53%, with operating and profit margins of 21.71% and 12.24%.

Gross Margin	61.53%
Operating Margin	21.71%
Pretax Margin	13.79%
Profit Margin	12.24%
EBITDA Margin	39.96%
EBIT Margin	21.71%
FCF Margin	31.1%

Dividends & Yields

AMGN pays an annual dividend of $9.39, which amounts to a dividend yield of 3.2%.

Dividend Per Share	$9.39
Dividend Yield	3.2%
Dividend Growth (YoY)	5.78%
Payout Ratio	76.78%
Earnings Yield	2.9%
FCF Yield	7.37%

Dividend Details

Analyst Forecast

The average price target for AMGN is $315, which is 11.1% higher than the current price. The consensus rating is "Hold".

Price Target	$315
Price Target Difference	11.1%
Analyst Consensus	Hold
Analyst Count	17

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	$37.8
Lynch Upside	-86.67%
Graham Number	42.99
Graham Upside	-84.84%

Stock Splits

The last stock split was on Nov 22, 1999. It was a forward split with a ratio of 2:1.

Last Split Date	Nov 22, 1999
Split Type	forward
Split Ratio	2:1

Scores

Altman Z-Score	1.62
Piotroski F-Score	8